A Phase Ib/II Study of Sotorasib Combined with Chemotherapy for Second Line Treatment of KRAS p. G12C Mutated Advanced Pancreatic Cancer

Status: Open to Accrual 

Learn More: 

• clinicaltrials.gov: #NCT05251038  

Study Contact: studies@hoosiercancer.org; (317) 921-2050.